Guidelines for oncologic surveillance in a patient with established cirrhosis
DOI:
https://doi.org/10.12775/QS.2024.16.52495Keywords
cirrhosis, hepatocellular carcinoma, oncologic surveillanceAbstract
Cirrhosis is a chronic, diffuse disease process characterized by fibrosis and remodeling of the organ's normal architectonics into regenerative nodules. It is also one of the risk factors for cancers of the organ. One of the most common is hepatocellular carcinoma (HCC). The etiologic agent of HCC, which usually also causes cirrhosis, can be determined in more than 90% of patients. The annual risk of developing HCC ranges from 1% to 8%. It is estimated that about 1/3 of cirrhotic patients will develop HCC. By preventing cirrhosis and controlling its course, we reduce the risk of hepatocellular carcinoma [1].
References
Krzakowski M, Reguła J, Cichoż-Lach H. Wytyczne postępowania diagnostyczno-terapeu- tycznego w raku wątrobowokomórkowym. Gastroenterologia Kliniczna 2022; 14(1): 1–57.
Smith A, Baumgartner K, Bositis C. Cirrhosis: Diagnosis and Management. Am Fam Physician. 2019 Dec 15;100(12):759-770. PMID: 31845776.
Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, Loomba R. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023 Jun;20(6):388-398. doi: 10.1038/s41575-023-00759-2. Epub 2023 Mar 28. PMID: 36977794; PMCID: PMC10043867.
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023 Aug;79(2):516-537
"Sytuacja zdrowotna ludności Polski i jej uwarunkowania 2022", pod redakcją: Bogdana Wojtyniaka i Pawła Goryńskiego, Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy, Warszawa 2022
„Zdrowa wątroba” Krajowy Program Prozdrowotny Kraków, 2018 http://ptmp.org.pl/wp-content/uploads/2016/10/zdrowa_watroba_info.pdf Dostęp na dzień 2.08. 2023
Rozpoznawanie i leczenie raka wątrobowokomórkowego – rekomendacje Sekcji Hepatologicznej Polskiego Towarzystwa Gastroenterologii Gastroenterologia Kliniczna 2015, tom 7, nr 3, 65-89
Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int. 2013 Feb;110(6):85-91. doi: 10.3238/arztebl.2013.0085. Epub 2013 Feb 8. PMID: 23451000; PMCID: PMC3583179.
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2017; 67: 370-98.
Zalecenia Polskiej Grupy Ekspertów HBV dotyczące leczenia przewlekłego wirusowego zapalenia wątroby typu B w 2018 roku
Rekomendacje leczenia wirusowych zapaleń wątroby typu C w roku 2023 Polskiej Grupy Ekspertów HCV
Wilson R, Williams DM. Cirrhosis. Med Clin North Am. 2022 May;106(3):437-446. doi: 10.1016/j.mcna.2021.12.001. Epub 2022 Apr 4. PMID: 35491064.
https://podyplomie.pl/pediatria/12151,markery-przewleklej-niewydolnosci-watroby?page=7
Grądalski, Tłum Wojciech. "Niewydolność wątroby puka do drzwi." Clinical Medicine 10.1 (2010).
https://www.mp.pl/interna/chapter/B16.II.7.12.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel; Chair:; EASL Governing Board representative:; Panel members:. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021 Sep;75(3):659-689. doi: 10.1016/j.jhep.2021.05.025. Epub 2021 Jun 21. PMID: 34166721.
European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-264.
Geng XX, Huang RG, Lin JM, et al. Transient elastography in clinical detection of liver cirrhosis: a systematic review and meta-analysis. Saudi J Gastroenterol. 2016;22(4):294-303.
Ferraioli G, Barr RG. Ultrasound liver elastography beyond liver fibrosis assessment. World J Gastroenterol. 2020 Jun 28;26(24):3413-3420. doi: 10.3748/wjg.v26.i24.3413. PMID: 32655265; PMCID: PMC7327790.
Rinaldi L, Giorgione C, Mormone A, Esposito F, Rinaldi M, Berretta M, Marfella R, Romano C. Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review. Viruses. 2023 Aug 13;15(8):1730. doi: 10.3390/v15081730. PMID: 37632072; PMCID: PMC10459581.
Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020 Jan 20;2(2):100067. doi: 10.1016/j.jhepr.2020.100067. PMID: 32118201; PMCID: PMC7047178.
Udell JA, Wang CS, Tinmouth J, et al. Does this patient with liver disease have cirrhosis?. JAMA. 2012;307(8):832-842.
Lurie Y, Webb M, Cytter-Kuint R, et al. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol. 2015;21(41):11567-11583.
Meseeha M, Attia M. Esophageal Varices. 2023 Aug 7. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 28846255.
Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases [published correction appears in Hepatology. 2017;66(1):304]. Hepatology. 2017;65(1):310-335.
A] Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13. PMID: 20392703; PMCID: PMC2886201.
Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol. 2014 Jun 21;20(23):7286-97. doi: 10.3748/wjg.v20.i23.7286. PMID: 24966599; PMCID: PMC4064074.
Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients. 2021 Feb 7;13(2):540. doi: 10.3390/nu13020540. PMID: 33562292; PMCID: PMC7915767.
Ge, Phillip S., and Bruce A. Runyon. "Treatment of patients with cirrhosis." New England Journal of Medicine 375.8 (2016): 767-777.
Plank LD, Gane EJ, Peng S, et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology2008;48:557-566
Rondon-Berrios H, Velez JCQ. Hyponatremia in Cirrhosis. Clin Liver Dis. 2022 May;26(2):149-164. doi: 10.1016/j.cld.2022.01.001. Epub 2022 Apr 1. PMID: 35487602; PMCID: PMC9060324
Bernardi, Mauro, Carmen Serena Ricci, and Luca Santi. "Hyponatremia in patients with cirrhosis of the liver." Journal of clinical medicine 4.1 (2014): 85-101.
Hanafy AS, Abd-Elsalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis. Vascul Pharmacol. 2019 Feb;113:86-91. doi: 10.1016/j.vph.2018.05.002. Epub 2018 Jun 7. Retraction in: Vascul Pharmacol. 2023 Jan 12;:107142. PMID: 29886103.
O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019 Jul;157(1):34-43.e1. doi: 10.1053/j.gastro.2019.03.070. Epub 2019 Apr 12. PMID: 30986390
Jakab SS, Garcia-Tsao G. Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis. Clin Liver Dis. 2020 Aug;24(3):335-350. doi: 10.1016/j.cld.2020.04.011. Epub 2020 May 31. PMID: 32620275.
Pimentel R, Gregório C, Figueiredo P. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in liver cirrhosis: systematic review. Acta Gastroenterol Belg. 2021 Apr-Jun;84(2):333-342. doi: 10.51821/84.2.333. PMID: 34217185.
Mattos AA, Wiltgen D, Jotz RF, Dornelles CMR, Fernandes MV, Mattos Z. Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis. Ann Hepatol. 2020 Sep-Oct;19(5):451-457. doi: 10.1016/j.aohep.2020.04.010. Epub 2020 Jun 6. PMID: 32533951.
Kim RG, Loomba R, Prokop LJ, Singh S. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017 Oct;15(10):1521-1530.e8. doi: 10.1016/j.cgh.2017.04.039. Epub 2017 May 4. PMID: 28479502; PMCID: PMC5605397.
Kucharska, Marta, and Krzysztof Simon. "Algorytmy diagnostyki i terapii u pacjenta z wodobrzuszem w przebiegu marskości wątroby." Hepatologia 14 (2014): 26-33.
Panasiuk, Anatol. "Encefalopatia wątrobowa." Forum Medycyny Rodzinnej. Vol. 8. No. 2. 2014.
Kaya E, Daniel Mazzolini G, Yilmaz Y, Canbay A. Prevention of hepatocellular carcinoma and monitoring of high-risk patients. Hepatol Forum. 2022 Jan 9;3(1):33-38. doi: 10.14744/hf.2021.2021.0033. PMID: 35782375; PMCID: PMC9138915.
Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604. doi: 10.1038/s41575-019-0186-y. Epub 2019 Aug 22. PMID: 31439937; PMCID: PMC6813818.
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913. PMID: 29624699.
Chen LT, Martinelli E, Cheng AL, Pentheroudakis G, Qin S, Bhattacharyya GS, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO. Ann Oncol 2020;31(3):334-351.
Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, Han JK, Choi BI. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology. 2015 Apr;275(1):97-109. doi: 10.1148/radiol.14140690. Epub 2015 Jan 5. PMID: 25559230.
Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, Waljee AK, Singal AG. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis. Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6. PMID: 29425931; PMCID: PMC5927818.
Colli A, Nadarevic T, Miletic D, Giljaca V, Fraquelli M, Štimac D, Casazza G. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013346. doi: 10.1002/14651858.CD013346.pub2. PMID: 33855699; PMCID: PMC8078581.
Wang T, Zhang KH. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Front Oncol. 2020 Aug 14;10:1316. doi: 10.3389/fonc.2020.01316. PMID: 32923383; PMCID: PMC745692.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis [published correction appears in J Hepatol. 2018;69(5):1207]. J Hepatol. 2018;69(2):406-460.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018; 69(1): 182–236, doi: 10.1016/j.jhep.2018.03.019, indexed in Pubmed: 29628281.
Bolondi L, Gaiani S, Celli N, et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology. 2005; 42(1): 27–34, doi: 10.1002/hep.20728, indexed in Pubmed: 15954118.
Cucchetti A, Piscaglia F, Cescon M, et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013; 59(2): 300–307, doi: 10.1016/j. jhep.2013.04.009, indexed in Pubmed: 23603669.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anita Janus, Dawid Łoś, Agata Kaptur, Dawid Dziedziński, Aleksandra Nowak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 170
Number of citations: 0
